验证数据展示
经过测试的应用
Positive IF/ICC detected in | HeLa cells |
Positive FC (Intra) detected in | HeLa cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
CL488-67843 targets CIP2A in IF/ICC, FC (Intra) applications and shows reactivity with human, rat samples.
经测试应用 | IF/ICC, FC (Intra) Application Description |
经测试反应性 | human, rat |
免疫原 | CIP2A fusion protein Ag19598 种属同源性预测 |
宿主/亚型 | Mouse / IgG1 |
抗体类别 | Monoclonal |
产品类型 | Antibody |
全称 | KIAA1524 |
别名 | KIAA1524, Protein CIP2A, p90 autoantigen, p90, Cancerous inhibitor of PP2A |
计算分子量 | 905 aa, 102 kDa |
观测分子量 | 102 kDa |
GenBank蛋白编号 | BC130564 |
基因名称 | CIP2A |
Gene ID (NCBI) | 57650 |
RRID | AB_2923799 |
偶联类型 | CoraLite® Plus 488 Fluorescent Dye |
最大激发/发射波长 | 493 nm / 522 nm |
形式 | Liquid |
纯化方式 | Protein G purification |
UNIPROT ID | Q8TCG1 |
储存缓冲液 | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA , pH 7.3 |
储存条件 | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Cancerous inhibitor of protein phosphatase 2A (CIP2A) was originally identified as a cellular protein phosphatase 2A (PP2A) inhibitor, and has been shown to control oncogenic cellular signals by suppressing the tumor suppressor PP2A. CIP2A overexpression has been found in several human malignancies including breast cancer, hepatocellular carcinoma, gastric cancer, head and neck cancer, colon cancer, prostate cancer and non-small cell lung cancer. CIP2A is a 83~102 kDa cytoplasmic protein. ( PMID: 26824320, PMID: 25458953, PMID: 29720672)
实验方案
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 488 CIP2A antibody CL488-67843 | Download protocol |
FC protocol for CL Plus 488 CIP2A antibody CL488-67843 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |